Valuation Alkem Laboratories Limited Bombay S.E.

Stocks

Market Closed - Bombay S.E. Other stock markets 11:00:52 22/07/2026 BST			5-day change	1st Jan Change
5,588.75 ^INR	-1.65%		-0.17%	+1.52%

06-02	Alkem Laboratories Limited Launches Semaglutide in Single-Shot Pre-Filled Syringes At Price Starting Inr 350	CI
06-02	Alkem Laboratories Shows Strong Moves But Weak Follow-Through

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	331,171	432,909	406,055	590,890	583,680	667,687	-	-
Change	-	30.72%	-6.2%	45.52%	-1.22%	14.39%	-	-
Enterprise Value (EV) ¹	328,603	433,805	393,853	587,236	578,678	632,481	645,954	632,578
Change	-	32.02%	-9.21%	49.1%	-1.46%	9.3%	1%	-2.07%
P/E	20.9x	26.3x	41.3x	32.9x	27x	27.5x	29.1x	25.3x
PBR	4.49x	5.01x	4.49x	5.73x	4.87x	4.58x	4.43x	3.9x
PEG	-	6.89x	-1x	0.4x	1.3x	4.37x	-3.83x	1.7x
Capitalization / Revenue	3.74x	4.07x	3.5x	4.66x	4.5x	4.31x	4.04x	3.67x
EV / Revenue	3.71x	4.08x	3.4x	4.64x	4.46x	4.3x	3.91x	3.47x
EV / EBITDA	16.9x	21.1x	24.5x	26.2x	23x	21x	19x	16.3x
EV / EBIT	19.7x	24.8x	30.3x	30.2x	26.9x	24.1x	21.8x	18.6x
EV / FCF	30.4x	55.4x	27.1x	33.3x	45.3x	42.8x	35.6x	30.4x
FCF Yield	3.29%	1.81%	3.69%	3%	2.21%	2.33%	2.81%	3.29%
Dividend per Share ²	28	34	25	40	45	53	51.35	56.59
Rate of return	1.01%	0.94%	0.74%	0.81%	0.92%	1%	0.9%	1%
EPS ²	132.6	137.6	82.31	150.2	181.1	192.5	195.3	224.3
Distribution rate	21.1%	24.7%	30.4%	26.6%	24.8%	27.5%	26.3%	25.2%
Net sales ¹	88,650	106,342	115,993	126,676	129,645	147,123	165,371	182,166
EBITDA ¹	19,424	20,529	16,094	22,455	25,122	30,052	34,011	38,779
EBIT ¹	16,678	17,490	12,990	19,462	21,550	26,232	29,653	34,085
Net income ¹	15,850	16,456	9,842	17,958	21,655	23,018	23,589	27,377
Net Debt ¹	-2,568	896.1	-12,202	-3,654	-5,003	-1,094	-21,733	-35,109
Reference price ²	2,769.80	3,620.70	3,396.10	4,942.00	4,881.70	5,681.50	5,681.50	5,681.50
Nbr of stocks (in thousands)	119,565	119,565	119,565	119,565	119,565	119,550	-	-
Announcement Date	25/05/21	13/05/22	19/05/23	29/05/24	29/05/25	28/05/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	34.93x	12.49x	26.13x	0.58%	1,048B
JOHNSON & JOHNSON	26.93x	6.14x	16.82x	2.14%	603B
ABBVIE INC.	33.36x	7.57x	15.52x	2.68%	452B
ROCHE HOLDING AG	17.83x	4.42x	10.88x	3%	327B
NOVARTIS AG	21.97x	5.47x	13.3x	2.81%	283B
ASTRAZENECA PLC	20.86x	4.4x	12.18x	2%	259B
NOVO NORDISK A/S	14.29x	5.31x	10.95x	3.5%	219B
AMGEN INC.	24.02x	6.34x	11.18x	2.75%	198B
GILEAD SCIENCES, INC.	-46.93x	5.62x	31.07x	2.53%	162B
Average	16.36x	6.42x	16.45x	2.44%	394.63B
Weighted average by Cap.	24.13x	7.79x	18.21x	2.01%